L-arginine and atherothrombosis

Journal of Nutrition

Volumn 134, Issue 10 SUPPL., 2004, Pages

  Loscalzo, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arginine; Atherothrombosis; Nitric oxide; Vasodilation

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; CREATINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANIDINOACETIC ACID; HISTAMINE; HOMOCYSTEINE; INSULIN; METHYL GROUP; NITRIC OXIDE; NORADRENALIN; S ADENOSYLHOMOCYSTEINE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CONFERENCE PAPER; DIET SUPPLEMENTATION; HUMAN; INSULIN RELEASE; MAST CELL; METHYLATION; NONHUMAN; THROMBOSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 4744367469     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2798s     Document Type: Conference Paper

References (25)

1. Creager, M. A., Gallagher, S. M., Girerd, X. J., Coleman, S. M., Dzau, V. J. & Cooke, J. P. (1992) L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 90: 1248-1253.
2. Dubois-Rande, J. L., Zelinsky, R., Roudot, F., Chabrier, P. E., Castaigne, A., Gerschwind, H. & Adnot, S. (1992) Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am. J. Cardiol. 70: 1269-1275.
3. McDonald, K. K., Zharikov, S., Block, E. R. & Kilberg, M. S. (1997) A caveolar complex between the cationic amino acid transporter I and endothelial nitric oxide synthase may explain the "arginine paradox." J. Biol. Chem. 272: 31213-31216.
4. Pollock, J. S., Forstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M. & Murad, F. (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88: 10480-10484.
5. Jay, M. T., Chirico, S., Siow, R. C., Bruckdorfer, K. R., Jacobs, J., Leake, D. S., Pearson, J. D. & Mann G. E. (1997) Modulation of vascular tone by low-density lipoproteins: effects on L-arginine transport and nitric oxide synthesis. Exp. Physiol. 82: 349-360.
6. Kikuta, K., Sawamura, T., Miwa, S., Hashimoto, N. & Masaki, T. (1998) High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. Circ. Res. 83: 1088-1096.
7. Miyazaki, H., Matsuoka, H., Cooke, J. P., Usiu, M., Ueda, S., Okuda, S. & Imaizumi, T. (1999) Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99: 1141-1146.
8. Boger, R. H., Bode-Boger, S. M., Mugge, A., Kienke, S., Brandes, R., Dwenger, A. & Frolich, J.C. (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117: 273-284.
9. Giraldelo, C. M., Zappellini, A., Muscara, M. N., DeLuca, I. M., Hyslop, S., Cirino, G., Zatz, R., DeNucci, G. & Antunes, E. (1994) Effect of arginine analogues on rat hind paw oedema and mast cell activation in vitro. Eur. J. Pharmacol. 257: 87-93.
10. Chin-Dusting, J. P., Alexander, C. T., Arnold, P. J., Hodgson, W. C., Lux, A. S. & Jennings, G. L. (1996) Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels. J. Cardiovasc. Pharmacol. 28: 158-166.
11. Giugliano, D., Marfella, R., Verrazzo, G., Acampora, R., Coppola, L., Cozzolino, D. & D'Onofrio, F. (1997) The vascular effects of L-arginine in humans: the role of endogenous insulin. J. Clin. Invest. 99: 433-438.
12. Zweier, J. L., Samouilov, A. & Kuppusamy, P. (1999) Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1411: 250-262.
13. Blum, A., Hathaway, L., Mincemoyer, R., Schenke, W. H., Kirby, M., Csako, G., Waclawis, M. A., Panza, J. A., Cannon, R. O., 3rd (2000) Oral L-arginine in patients with coronary artery disease on medical management. Circulation 101: 2160-2164.
14. Loscalzo, J. (2000) What we know and don't know about L-arginine and NO. Circulation 101: 2126-2129.
15. Vasquez-Vivar, J., Duquaine, D., Whitsett, J., Kalyanaraman, B. & Rajagopalan, S. (2002) Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for the use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterio. Thromb. Vasc. Biol. 22: 1655-1661.
16. Buttery, L. D., Springall, D. R., Chester, A. H., Evans, T. J., Standfield, E. N., Parums, D. V., Yacoub, M. H. & Polak, J. M. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes formation and activity of peroxynitrite. Lab. Invest. 75: 77-85.
17. Detmers, P. A., Hernandez, M., Mudgett, J., Hassing, H., Burton, C., Mundt, S., Chun, S., Fletcher, D., Card, D. J., Lisnock, J., Weikel, R., Bergstrom, J. D., Shevell, D. E., Hermanowski, Vosatka, A., Sparrow, C. P., Chao, Y. S., Rader, D. J., Wright, S. D. & Pure, E. (2000) Deficiency in inducible nitric oxide synthase results in reduced athersclerosis in apolipoprotein E-deficient mice. J. Immunol. 165: 3430-3435.
18. Kuhlencordt, P. J., Chen, J., Han, F., Astern, J. & Huang, P. L. (2001) Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103: 3099-3104.
19. Chen, J., Kuhlencordt, P., Urano, F., Ichinose, H., Astern, J. & Huang, P.L. (2003) Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout mice and apoE/iNOS double knockout mice. Arterio. Thromb. Vasc. Biol. 22: 97-103.
20. Loscalzo, J. (2003) Adverse effects of supplemental L-arginine in atherosclerosis. Consequences of methylation stress in a complex catabolism? Arterio. Thromb. Vasc. Biol. 22: 3-5.
21. 15N]citrulline labeling. Proc. Natl. Acad. Sci. U.S.A. 93: 11460-11465.
22. Wyss, M. & Kaddurah-Daouk, R. (2000) Creatine and creatinine metabolism. Physiol. Rev. 80: 1107-1213.
23. Chen, P., Poddar, R., Tipa, E. V., Dibello, P. M., Moravec, C. D., Robinson, K., Green, R., Kruger, W. D., Garrow, T. A. & Jacobsen, D. W. (1999) Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. Adv. Enzyme Regul. 39: 93-109.
24. Stuhlinger, M. C., Tsao, P. S., Her, J. H., Kimoto, M., Balint, R. F. & Cooke, J. P. (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104: 2569-2575.
25. Stead, L. M., Au, K. P., Jacobs, R. L., Brosnan, M. E. & Brosnan, J. T. (2001) Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. Am. J. Physiol. Endocrinol. Metab. 281: E1095-E1100.